Clinical Trials Sponsored by Inreda Diabetic

Total 4052 results

Medtronic Diabetes

Completed

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance (6-DayFU)

Diabetes

United States
Medtronic Diabetes

Completed

Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness (STAR2)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Effectiveness Study of the Guardian RT in Type 1 Diabetics

Type 1 Diabetes Mellitus

Slovenia, United Kingdom, France, Germany, Israel, Italy, Sweden
Centre d'Alt Rendiment
University of Barcelona; Indena S.p.A; Hospital Sant Joan de Deu

Completed

Bioavailability and Impact of Coenzyme Q10 in Stressing Exercise in Senescence Athletes (CoQ10Sport)

Aging | Oxidative Stress | Coenzyme Q10

Spain
University of Messina
Natasha Irrera; Gianluca Di Bella; Antonio Micari; Roberto Licordari

Recruiting

Modulation of Fibrosis-inducing Pathways in Acute Myocardial Infarction (BETA-MI)

Myocardial Infarction | Myocardial Fibrosis | Myocardial Remodeling, Ventricular

Italy
Joslin Diabetes Center
American Diabetes Association

Completed

Metabolic Effects of Betaine Supplementation

Obesity | Dysglycemia

United States
Medtronic Diabetes
Juvenile Diabetes Research Foundation

Completed

Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia (ePID-03)

Type 1 Diabetes Mellitus

United States
Lund University
Anti-Diabetic Food Centre

Completed

Postprandial Effects of Mixed Herbs and Spices on Pathways Associated With Glucose Homeostasis and Inflammation on PBMCs of Healthy Subjects

Healthy

Sweden
Lund University
Anti-Diabetic Food Centre

Completed

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

Healthy Subjects

Sweden
Lund University
Anti-Diabetic Food Centre

Completed

Effects of Legumes on Glucose Regulation

Dietary Prevention

Sweden
Medtronic Diabetes

Recruiting

In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

Type 2 Diabetes Treated With Insulin

United States
Medtronic Diabetes

Completed

Use of the Guardian™ Connect System With Smart Connected Devices

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States, China
Medtronic Diabetes

Completed

Feasibility Studies of Personalized Closed Loop

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Medtronic Diabetes

Completed

Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes

Diabetes

United States
Medtronic Diabetes

Withdrawn

A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics

Type 1 Diabetes | Type 2 Diabetes
Medtronic Diabetes

Completed

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

Type 1 Diabetes | Type 2 Diabetes

United States
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
Medtronic Diabetes

Completed

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Medtronic Diabetes

Completed

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Diabetes

United States
Medtronic Diabetes

Completed

Routine Use of Sensor-Augmented Pump Therapy - a Follow up Study

Diabetes

Sweden
Medtronic Diabetes

Completed

Obtain a Good Blood Glucose Control With the Paradigm Real Time System (RTD)

Type 1 Diabetes

France
Medtronic Diabetes

Completed

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy (STAR3)

Type 1 Diabetes

United States, Canada
Medtronic Diabetes

Completed

An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Withdrawn

A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics

Type 1 Diabetes
Medtronic Diabetes

Completed

In Clinic Evaluation of the PLGM Feature (PLGM)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy

Type 2 Diabetes

China
Medtronic Diabetes

Completed

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes (STAR1)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Withdrawn

A Performance Evaluation of the Enlite 3 Sensor

Type 1 Diabetes

United States
Steno Diabetes Center Copenhagen
Juvenile Diabetes Research Foundation; Oeresund Diabetes Academy

Completed

Anti-Interleukin-1 in Diabetes Action (AIDA)

Type 1 Diabetes

Spain, Denmark, Netherlands, Germany, Italy, Poland, Switzerland
Joslin Diabetes Center
Abbott Diabetes Care

Completed

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Hypoglycemia

United States
Joslin Diabetes Center
American Diabetes Association

Completed

Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study (DISCO)

Diabetes

United States
Joslin Diabetes Center
American Diabetes Association

Completed

Using Conversation Maps to Reinforce Self-Care

Type 2 Diabetes

United States
Anthony Hanley
Canadian Diabetes Association; Canadian Foundation for Dietetic Research (CFDR)

Completed

Gestational Metabolic Abnormalities and Maternal and Infant Nutrition and Health

Hyperglycemia | Obesity | Insulin Resistance | Gestational Diabetes

Canada
Lund University
Anti-Diabetic Food Centre

Completed

Effect of Herbs and Spices on Metabolic Regulation and Appetite in Healthy Subjects (AFC-SPICES)

Healthy

Sweden
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Type 1 Diabetes

United States, Canada, Australia
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed 780 System in Paediatric Subjects (LENNY)

Diabetes type1 | Children, Only

Italy, United Kingdom, Finland, Slovenia
Medtronic Diabetes

Completed

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

InPen User Experience

Diabetes Type 1

Sweden
Medtronic Diabetes

Completed

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Type 1 Diabetes

Israel
Medtronic Diabetes

Completed

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

United Kingdom User Evaluation, MiniMed Paradigm® X54 System (X54User)

Diabetes Mellitus, Type 1

United Kingdom
Medtronic Diabetes

Completed

The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.

Type 1 Diabetes

France
Medtronic Diabetes

Completed

MiniMed™ 670G System China Study for Type I Diabetic

Diabetes Mellitus, Type 1

China
Medtronic Diabetes

Completed

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Type 1 Diabetes Mellitus | Type2 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

New Glucose Sensor Pediatric

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes (SMILE)

Type 1 Diabetes

Netherlands, France, Italy, United Kingdom
DreaMed Diabetes

Unknown

Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections

Diabetes Mellitus

Israel

Clinical Trials Sponsored by Inreda Diabetic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations